1. Introduction {#sec1-molecules-23-01510}
===============

*Junceella fragilis* (Ridley, 1884) (family Ellisellidae) \[[@B1-molecules-23-01510],[@B2-molecules-23-01510],[@B3-molecules-23-01510]\], a gorgonian coral, has been reported to contain high levels of diterpenoids with a briarane carbon skeleton. These diterpenoids often have complex structures and possess varied bioactivities \[[@B4-molecules-23-01510],[@B5-molecules-23-01510],[@B6-molecules-23-01510],[@B7-molecules-23-01510],[@B8-molecules-23-01510],[@B9-molecules-23-01510]\]. In further studies of the chemical constituents of *J. fragilis*, two new briaranes---fragilides K (**1**) and L (**2**)---and five known analogues---gemmacolide X (**3**) \[[@B10-molecules-23-01510]\], praelolide (**4**) \[[@B11-molecules-23-01510],[@B12-molecules-23-01510],[@B13-molecules-23-01510],[@B14-molecules-23-01510],[@B15-molecules-23-01510],[@B16-molecules-23-01510]\], juncins P (**5**) and ZI (**6**) \[[@B16-molecules-23-01510],[@B17-molecules-23-01510]\], and gemmacolide V (**7**) \[[@B10-molecules-23-01510]\]---were obtained ([Figure 1](#molecules-23-01510-f001){ref-type="fig"}). In this study, we isolated and determined the structures of these briaranes, and performed anti-inflammatory assays to determine their anti-inflammatory activities in terms of targeting inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 (COX-2) in a macrophage in vitro system.

2. Results and Discussion {#sec2-molecules-23-01510}
=========================

Fragilide K (**1**), \[α\]${}_{D}^{22}$ --43 (*c* 0.02, CHCl~3~), was obtained as an amorphous powder. The molecular formula of **1** was established as C~28~H~35~ClO~13~ (11 degrees of unsaturation) from a sodiated molecule at *m*/*z* 637 in the electrospray ionization mass spectrum (ESIMS), and further supported by the high-resolution electrospray ionization mass spectrum (HRESIMS) at *m*/*z* 637.16613 (calcd. for C~28~H~35~ClO~13~ + Na, 637.16584). The IR spectrum of **1** demonstrated bands at 3545, 1790, and 1740 cm^--1^, which were consistent with the presence of hydroxy, γ-lactone, and ester carbonyl groups. The ^13^C NMR and distortionless enhancement by polarization transfer (DEPT) spectra showed that **1** had 28 carbons ([Table 1](#molecules-23-01510-t001){ref-type="table"}): 6 methyls, 2 sp^3^ methylenes, 10 sp^3^ methines, 3 sp^3^ quaternary carbons, 1 sp^2^ methylene, and 6 sp^2^ quaternary carbons.

From the ^1^H and ^13^C NMR spectra ([Table 1](#molecules-23-01510-t001){ref-type="table"}), **1** was found to possess four acetoxy groups (δ~H~ 2.32, 2.08, 2.05, 2.00, each 3H × s; δ~C~ 21.1, 21.1, 20.5, 20.3, acetate methyl × 4; δ~C~ 169.5, 169.9, 170.2, 169.9, acetate carbonyl × 4), a γ-lactone moiety (δ~C~ 174.2), and an exocyclic carbon--carbon double bond (δ~C~ 134.1, C; 119.7, CH~2~; δ~H~ 5.36, 1H, d, *J* = 1.6 Hz; 5.57, 1H, d, *J* = 1.6 Hz). Thus, based on the aforementioned data, six degrees of unsaturation were accounted for, and **1** was identified as a pentacyclic compound. The presence of an exocyclic epoxy group was confirmed from the signals of an oxygenated quaternary carbon at δ~C~ 58.9 (C) and an oxymethylene at δ~C~ 50.6 (CH~2~). The chemical shifts of oxymethylene protons at δ~H~ 2.76 (1H, d, *J* = 3.2 Hz) and 2.56 (1H, d, *J* = 3.2 Hz) supported the presence of this group. From the ^1^H--^1^H correlation spectroscopy (COSY) spectrum of **1**, four different structural units, H-2/H-3/H-4, H-6/H-7, H-12/H~2~-13/H-14, and H-17/H~3~-18, were identified ([Table 1](#molecules-23-01510-t001){ref-type="table"}), which were assembled with the assistance of a heteronuclear multiple-bond coherence (HMBC) experiment ([Table 1](#molecules-23-01510-t001){ref-type="table"}). The HMBC correlations between protons and quaternary carbons of **1**, such as H-2, H-3, H-9, H-10, H~3~-15/C-1; H-3, H-4, H-7/C-5; H-4, H-10, H~3~-18/C-8; H-9, H-10/C-11; and H-17, H~3~-18/C-19, permitted elucidation of the carbon skeleton of **1**. An exocyclic double bond at C-5 was confirmed by the HMBC correlations between H~2~-16/C-4, C-6. The ring junction C-15 methyl group was positioned at C-1 from the HMBC correlations between H~3~-15/C-1, C-2, C-10, C-14 and H-2, H-10/C-15. The acetoxy groups at C-2, C-3, and C-9 were established by correlations between H-2 (δ~H~ 5.50), H-3 (δ~H~ 6.22), H-9 (δ~H~ 5.60) and the acetate carbonyls at δ~C~ 170.2, 169.9, 169.5, observed in the HMBC spectrum of **1**. The remaining hydroxy group and acetate ester were positioned at C-12 and C-14, respectively, as indicated by characteristic ^1^H NMR signal analysis (δ~H~, 3.49, 1H, br s, H-12; 5.01, 1H, dd, *J* = 3.2, 3.2 Hz, H-14).

From the ESIMS spectrum \[(M + Na)^+^:(M + 2 + Na)^+^ = 3:1\], the intensity of the sodiated molecule isotope peak \[M + 2 + Na\]^+^ was noted, which confirmed the presence of a chlorine atom in **1**. The methine unit at δ~C~ 53.8 (CH) was more shielded than would be expected for an oxygenated C-atom and was correlated with the methine proton at δ~H~ 4.96 in the heteronuclear single-quantum coherence (HSQC) spectrum; this proton also showed a ^3^*J*-correlation with H-7 in the ^1^H--^1^H COSY spectrum, confirming the attachment of a chlorine atom at C-6. In addition, the methylene unit at δ~C~ 50.6 was correlated with the methylene protons at δ~H~ 2.76 and 2.56 in the HSQC spectrum, and the HMBC correlations between H-9, H-10/C-11 (an oxygenated quaternary carbon, δ~C~ 58.9), and H-10/C-20, confirmed the attachment of an epoxy group at C-11/20. Furthermore, an HMBC correlation between H-4 (δ~H~ 4.49) and an oxygenated quaternary carbon at δ~C~ 83.0 (C-8) suggested the presence of a C-4/8 ether linkage in **1**.

From the findings of previous surveys, all briaranes that exist naturally have H-10 trans to a C-15 methyl, and these two groups are assigned as α- and β-oriented in most briarane analogues \[[@B18-molecules-23-01510]\]. The relative stereochemistry of **1** was established from the interactions observed in a nuclear Overhauser effect spectroscopy (NOESY) experiment and by vicinal ^1^H--^1^H coupling constant analysis, which was corroborated by MM2 force field calculations ([Figure 2](#molecules-23-01510-f002){ref-type="fig"}) \[[@B19-molecules-23-01510]\], indicating the most stable configuration to be as shown in [Figure 2](#molecules-23-01510-f002){ref-type="fig"}. The results of the NOESY experiment showed correlations between H-10 and H-2, H-9, and H~3~-18 in **1**, suggesting that these protons were situated on the same face of the molecule, and therefore they were assigned as α protons, as Me-15 was β-oriented and H~3~-15 did not show a correlation with H-10. The oxymethine protons H-3 and H-14, and one proton of the C-20 methylene (δ~H~ 2.56, H-20b), were found to exhibit interactions with H~3~-15, but not with H-10, revealing that H-3 and H-14 were β-oriented, and the epoxy group between C-11/20 was α-oriented. H-12 exhibited correlations with one proton of the C-20 methylene (δ~H~ 2.76, H-20a) and the C-13 methylene protons, but not with H-10, indicating that the hydroxy group at C-12 was α-oriented. H-9 was found to show correlations with H-7, H-10, H-17, and H-20b. From modeling analysis, H-9 was found to be reasonably close to H-7, H-10, H-17, and H-20b, and could therefore be placed on the α face in **1**, and methine protons H-7 and H-17 were β-oriented. H-7 showed correlations with H-6 and H-17, and a small coupling constant was found between H-6 and H-7 (*J* = 2.8 Hz), indicating that H-6 was of a β-orientation. Moreover, H-4 showed correlations with H-2 and one proton of the C-16 methylene (δ~H~ 5.36, H-16a), and a large coupling constant was found between H-3 and H-4 (*J* = 10.8 Hz), indicating that H-4 was of an α-orientation. The chemical shifts of the exocyclic 11,20-epoxy groups in briarane analogues have been summarized, and the ^13^C NMR shifts for C-11 and C-20 appear at δ~C~ 55--61 and 47--52 ppm, respectively, the epoxy group is α-oriented (11*R*\*), and the cyclohexane ring is of a chair conformation \[[@B20-molecules-23-01510]\]. Based on the above findings, the 11,20-epoxy group in **1** (δ~C~ 58.9, C-11; 50.6, CH~2~-20) was α-oriented, and the cyclohexane ring in **1** was of a chair conformation. Therefore, based on the above findings, the configurations of the stereogenic centers of **1** were elucidated as 1*R*\*,2*R*\*,3*S*\*,4*R*\*,6*S*\*,7*R*\*,8*R*\*,9*S*\*, 10*S*\*,11*R*\*,12*R*\*,14*S*\*, and 17*R*\* (see [Figures S1--S9 in the Supplementary Materials](#app1-molecules-23-01510){ref-type="app"}).

Fragilide L (**2**) was obtained as an amorphous powder that gave an \[M + Na\]^+^ ion with *m*/*z* 531.22014 in the HRESIMS analysis, appropriate for the molecular formula C~26~H~36~O~10~ (calcd. for C~26~H~36~O~10~ + Na, 531.22007). Inspection of the IR spectrum revealed absorptions indicative of hydroxy (3447 cm^--1^), γ-lactone (1771 cm^--1^), and ester carbonyl (1731 cm^--1^) groups. From the ^1^H and ^13^C NMR data of **2** ([Table 2](#molecules-23-01510-t002){ref-type="table"}), an exocyclic carbon--carbon double bond was deduced from the signals of two carbons at δ~C~ 150.9 (C) and 113.1 (CH~2~); this was further supported by two olefin protons at δ~H~ 5.06 (1H, s) and 4.90 (1H, s). Moreover, four carbonyl resonances at δ~C~ 175.8, 171.8, 170.6, and 169.4 confirmed the presence of a γ-lactone and three other ester groups. All the esters were identified as acetates by the presence of three acetyl methyl resonances in the ^1^H (δ~H~ 2.21, 2.01, and 1.91, each 3H × s) and ^13^C (δ~C~ 21.8, 21.1, and 21.2) NMR spectra ([Table 2](#molecules-23-01510-t002){ref-type="table"}). It was found that the NMR data of **2** were similar to those of a known analogue, junceellonoid B (**8**) ([Figure 1](#molecules-23-01510-f001){ref-type="fig"}) \[[@B21-molecules-23-01510]\], with the exception that the signals corresponding to the 16-acetoxy group in **8** were replaced by a hydroxy group in **2**. From the HMBC correlations, the presence of olefinic carbons at δ~C~ 146.7 (C) and 121.7 (CH), and oxygen-bearing methylene protons at δ~H~ 4.28 and 4.14, was noted, and a hydroxy group was deduced to be attached at C-16 in **2** ([Table 2](#molecules-23-01510-t002){ref-type="table"}). The other HMBC correlations observed fully supported the locations of the functional groups, and hence fragilide L (**2**) was assigned with the structure of **2**, with the same stereochemistry as in junceellonoid B (**8**), because the stereogenic centers that **2** had in common with **8**, in addition to the ^1^H and ^13^C NMR chemical shifts and proton coupling constants matched well, and were further supported by a NOESY experiment.

The relative stereochemistry of **2** was elucidated from the NOE interactions observed in a NOESY experiment ([Figure 3](#molecules-23-01510-f003){ref-type="fig"}). Due to the α-orientation of H-10, the ring junction C-15 methyl group is β-oriented, as no correlation was observed between H-10 and H~3~-15. In the NOESY spectrum of **2**, H-10 was correlated to H-2 and H-9, suggesting that H-2 and H-9 were located on the same face and can be assigned as α protons. H-14 was found to exhibit a response with H~3~-15, but not with H-10, showing that this proton was β-oriented. It was found that H-17 showed NOE correlations with H-7 and H-9. Consideration of molecular models revealed that H-17 is reasonably close H-7 and H-9 when H-7 and H-17 were β-oriented. The NOE correlations between H-6 and H-10 suggested that the Δ^5^ double bond in the 10-membered ring was oriented in such a way that the H-6 is on the same side as H-10. The large coupling constant observed (*J* = 10.0 Hz) revealed the antiparallel arrangement of H-6 and H-7 and the β orientation of H-7. H-6 exhibited a correlation with one proton of C-16 oxymethylene (δ~H~ 4.14, H-16b), suggesting the *Z*-configuration of C-5/6 double bond. Furthermore, a proton of the C-20 methylene (δ~H~ 5.06, H-20b) was found to exhibit NOE responses with H-9 and H-10, but not with H~3~-15, and H~3~-15 showed a NOE correlation with one proton of C-12 methylene (δ~H~ 2.18, H-12b), indicating the cyclohexane ring of **2** should be presented as a twist boat rather than a chair conformation for briarane **2**.

In a previous study, the proton chemical shifts of the briarane derivatives containing an 11,20-exocyclic carbon--carbon double were summarized and the difference between the two olefin protons (H-20a/b) was smaller than 0.2 ppm, whereas the cyclohexane rings exhibited a twisted boat conformation \[[@B22-molecules-23-01510]\]. Owing to the chemical shifts of the C-20 methylene protons (δ~H~ 5.06 and 4.90), the configuration of the methylenecyclohexane ring in **2** was concluded to be of a twisted boat conformation. Based on the above findings, the configurations of the stereogenic centers of **2** were elucidated as 1*R*\*,2*S*\*,7*S*\*,8*R*\*,9*S*\*,10*S*\*,14*S*\*, and 17*R*\* ([Supplementary Materials](#app1-molecules-23-01510){ref-type="app"}, [Figures S10--S18](#app1-molecules-23-01510){ref-type="app"}).

Six known chlorinated briaranes were also isolated and were identified as gemmacolide X (**3**) \[[@B10-molecules-23-01510]\], praelolide (**4**) \[[@B11-molecules-23-01510],[@B12-molecules-23-01510],[@B13-molecules-23-01510],[@B14-molecules-23-01510],[@B15-molecules-23-01510],[@B16-molecules-23-01510]\], juncins P (**5**) and ZI (**6**) \[[@B16-molecules-23-01510],[@B17-molecules-23-01510]\], and gemmacolide V (**7**) \[[@B10-molecules-23-01510]\] by comparison with the spectroscopic and physical data reported in the literature.

Using an in vitro cell culture model with a murine macrophage RAW264.7 cell line, anti-inflammatory analysis was performed to assess the activities of the compounds. Western blotting was used to measure the changes in pro-inflammatory proteins iNOS and COX-2 in the lipopolysaccharide (LPS)-induced pro-inflammatory response of RAW264.7 macrophages. In comparison with cells treated with LPS alone, the macrophages treated with a concentration of 10 μM, briaranes **2**, **3**, and **6** resulted in decreases in iNOS to 49.13, 36.22, and 43.33%, respectively, and **3** and **7** elicited reduction of COX-2 to 43.64 and 47.49%, respectively ([Table 3](#molecules-23-01510-t003){ref-type="table"} and [Figure 4](#molecules-23-01510-f004){ref-type="fig"}). Briaranes **1**--**7** did not cause significant cell death according to trypan blue staining, which suggested that the compounds had a low cytotoxicity towards the macrophage cells. Briarane **3** showed suppression effects on the expression of pro-inflammatory iNOS and COX-2 proteins, while **1** and **4** were observed to be inactive in terms of reducing the levels of these two proteins. These results suggested that the bulky acetate at C-12 could significantly enhance anti-inflammatory activities.

3. Experimental Section {#sec3-molecules-23-01510}
=======================

3.1. General Experimental Procedures {#sec3dot1-molecules-23-01510}
------------------------------------

General experiment methods are as described in our previous study \[[@B23-molecules-23-01510]\].

3.2. Animal Material {#sec3dot2-molecules-23-01510}
--------------------

Specimens of the gorgonian coral *J. fragilis* were collected in June 2017 by hand by scuba divers off the coast of Southern Taiwan. The samples were then stored in a freezer until extraction. A voucher specimen was deposited in the National Museum of Marine Biology and Aquarium, Taiwan (NMMBA-TW-GC-2017-017). Identification of the species of this organism was performed by comparison as described in previous publication \[[@B1-molecules-23-01510],[@B2-molecules-23-01510],[@B3-molecules-23-01510]\].

3.3. Extraction and Isolation {#sec3dot3-molecules-23-01510}
-----------------------------

Sliced bodies of *J. fragilis* (wet weight 929 g, dry weight 374 g) were extracted with a mixture of methanol (MeOH) and dichloromethane (CH~2~Cl~2~) (v:v = 1:1). The extract (20.3 g) was partitioned between ethyl acetate (EtOAc) and H~2~O. The EtOAc layer (8.7 g) was separated on silica gel and eluted with *n*-hexane/EtOAc/MeOH (stepwise, v:v:v = 100:0:0 to 100% MeOH) to yield 14 subfractions A--N. Fraction I was purified by NP-HPLC using a mixture of *n*-hexane/acetone (v:v= 3:1 at a flow rate of 5.0 mL/min) to afford 15 subfractions I1--I15. Fraction I7 was purified by RP-HPLC using a mixture of acetonitrile/H~2~O (v:v= 1:1 at a flow rate of 1.0 mL/min) to yield **4** (0.6 mg). Fraction I9 was purified by NP-HPLC using a mixture of CH~2~Cl~2~/acetone (v:v = 15:1 at a flow rate of 2.0 mL/min) to yield **3** (81.9 mg) and **6** (0.7 mg). Fraction I14 was purified by NP-HPLC using a mixture of CH~2~Cl~2~/acetone (v:v = 15:1 at a flow rate of 2.0 mL/min) to yield **5** (0.9 mg) and **7** (2.7 mg). Fraction J was separated by silica gel column chromatography and then eluted with CH~2~Cl~2~/acetone (stepwise, v:v = 20:1 to 100% acetone) to afford 15 subfractions J1--J15. Fraction J12 was purified by NP-HPLC using a mixture of *n*-hexane/acetone (v:v = 2:1 at a flow rate of 2.0 mL/min) to yield **2** (1.2 mg). Fraction L was separated by silica gel column chromatography and then eluted with *n*-hexane/acetone (stepwise, v:v = 50:1 to 100% acetone) to afford eleven subfractions L1--L11. Fraction L9 was separated by silica gel column chromatography and then eluted with CH~2~Cl~2~/acetone (stepwise, v:v = 80:1 to 100% acetone) to afford 11 subfractions L9A--L9K. Fraction L9I was purified by NP-HPLC using a mixture of CH~2~Cl~2~/acetone (v:v = 15:1) to afford seven subfractions L9I1--L9I7. Fraction L9I2 was purified by RP-HPLC using a mixture of MeOH/H~2~O (v:v = 80:20 at a flow rate of 2.0 mL/min) to yield **1** (0.8 mg).

Fragilide K (**1**): amorphous powder; mp 136--138 °C; \[α\]${}_{D}^{22}$ −43 (*c* 0.02, CHCl~3~); IR (neat) ν~max~ 3545, 1790, 1740 cm^−1^; ^1^H (400 MHz, CDCl~3~) and ^13^C (100 MHz, CDCl~3~) NMR data (see [Table 1](#molecules-23-01510-t001){ref-type="table"}); ESIMS: *m*/*z* 637 \[M + Na\]^+^, 639 \[M + 2 + Na\]^+^; HRESIMS: *m*/*z* 637.16613 (calcd. for C~28~H~35~ClO~13~ + Na, 637.16584).

Fragilide L (**2**): amorphous powder; mp 129--131 °C; \[α\]${}_{D}^{22}$ −75 (*c* 0.06, CHCl~3~); IR (neat) ν~max~ 3447, 1771, 1731 cm^−1^; ^1^H (400 MHz, CDCl~3~) and ^13^C (100 MHz, CDCl~3~) NMR data (see [Table 2](#molecules-23-01510-t002){ref-type="table"}); ESIMS: *m*/*z* 531 \[M + Na\]; HRESIMS: *m*/*z* 531.22014 (calcd. for C~26~H~36~O~10~ + Na, 531.22007).

3.4. Molecular Mechanics Calculations {#sec3dot4-molecules-23-01510}
-------------------------------------

Implementation of the MM2 force field \[[@B19-molecules-23-01510]\] program in ChemBio 3D Ultra software from Cambridge Soft Corporation (ver. 12.0, Cambridge, MA, USA) was used to create molecular models.

3.5. In Vitro Anti-Inflammatory Assay {#sec3dot5-molecules-23-01510}
-------------------------------------

Murine macrophage-like cell line RAW264.7 was purchased from the American Type Culture Collection (ATCC, No TIB-71) (Manassas, VA, USA). The in vitro anti-inflammatory activities of compounds **1**--**7** were assessed by investigating their inhibition effects on LPS-induced pro-inflammatory iNOS and COX-2 protein expressions in the macrophage cell line using western blot analysis \[[@B24-molecules-23-01510],[@B25-molecules-23-01510],[@B26-molecules-23-01510]\]. Briefly, inflammation in macrophages was induced by incubating them for 16 h in a medium containing only LPS (10 μM) without compounds. For the anti-inflammatory activity assays, Briaranes **1**--**7** and dexamethasone (10 μM) were added to the cells 10 min before LPS challenge. The cells were then subjected to western blot analysis. The immunoreactivity data were calculated with respect to the average optical density of the corresponding LPS-stimulated group. The RAW264.7 macrophage cell viability was determined after treatment with alamar blue (invitrogen, Carlsbad, CA, USA), a tetrazolium dye that is reduced by living cells to fluorescent products. This assay is similar in principle to the cell viability assay using 3-(4,5-dimethldiazol-2-yl)-2,5-diphenyltetrazolium bromide and has been validated as an accurate measure of the survival of RAW264.7 macrophage cells \[[@B27-molecules-23-01510],[@B28-molecules-23-01510]\]. For statistical analysis, the data was analyzed by one-way analysis of variance (ANOVA), followed by the Student--Newman--Keuls *post hoc* test for multiple comparison. A significant difference was defined as a *p*-value of \< 0.05.

4. Conclusions {#sec4-molecules-23-01510}
==============

Gorgonian corals belonging to the family Ellisellidae have proven to be a rich source of interesting polyoxygenated and chlorinated briarane-related natural products with complex structures and extensive bioactivities. Fragilide L (**2**), gemmacolides X (**3**) and V (**7**), and juncin ZI (**6**), are compounds suitable for further study, as they have the potential to be developed as new medicinal agents. Among these compounds, we suggested that gemmacolide X (**3**) has more potential for its mass production from the target pharmaceutical-origin material *J. fragilis*. This interesting coral species has been transferred to culture tanks located in our institute to produce a large quantity of culture material. The cultured *J. fragilis* is used for the isolation of natural raw ingredients in order to establish a constant supply of bioactive materials.
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HRESIMS, IR, 1D (^1^H NMR, ^13^C NMR, and DEPT spectra), and 2D (HSQC, ^1^H−^1^H COSY, HMBC, and NOESY spectra) NMR spectra of new compounds **1** and **2** are available online.
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![Gorgonian coral *Junceella fragilis* and structures of fragilides K (**1**) and L (**2**), gemmacolide X (**3**), praelolide (**4**), juncins P (**5**) and ZI (**6**), gemmacolide V (**7**), and junceellonoid B (**8**).](molecules-23-01510-g001){#molecules-23-01510-f001}

![A model of **1** generated using a computer-assisted system based on the data from MM2 force field calculations and selected protons with key NOESY correlations.](molecules-23-01510-g002){#molecules-23-01510-f002}

![Selected protons with key NOESY correlations of **2**.](molecules-23-01510-g003){#molecules-23-01510-f003}

![Effects of compounds **1**--**7** on the expression of pro-inflammatory iNOS and COX-2 proteins in lipopolysaccharide (LPS)-treated murine RAW264.7 macrophage cells. West blotting showed that briaranes **2**, **3**, and **6** inhibited LPS-induced iNOS expressions and briaranes **3** and **7** downregulated the expression of COX-2. Data were normalized to the cells treated with LPS only, and cells treated with dexamethasone (10 μM) were used as a positive control (which reduced the iNOS and COX-2 levels to 30.83 and 9.32%, respectively). Data are expressed as the mean ± SEM (*n* = 4). **\*** Significantly different from cells treated with LPS (*p* \< 0.05).](molecules-23-01510-g004){#molecules-23-01510-f004}
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###### 

^1^H (400 MHz, CDCl~3~) and ^13^C (100 MHz, CDCl~3~) NMR data, ^1^H--^1^H COSY, and HMBC correlations for briarane **1**.

  C/H      δ~H~ (*J* in Hz)                                       δ~C~, Multiple   ^1^H--^1^H COSY   HMBC (H→C)
  -------- ------------------------------------------------------ ---------------- ----------------- -----------------------------------------
  1                                                               46.9, C                            
  2        5.50 d (6.8)                                           72.6, CH         H-3               C-1, C-3, C-4, C-15, acetate carbonyl
  3        6.22 dd (10.8, 6.8)                                    63.7, CH         H-2, H-4          C-1, C-4, C-5, acetate carbonyl
  4        4.49 d (10.8)                                          78.9, CH         H-3               C-3, C-5, C-6, C-8, C-16
  5                                                               134.1, C                           
  6        4.96 d (2.8)                                           53.8, CH         H-7               n\. o.
  7        4.42 d (2.8)                                           79.0, CH         H-6               C-5
  8                                                               83.0, C                            
  9        5.60 s                                                 71.1, CH         n\. o. ^a^        C-1, C-10, C-11, C-17, acetate carbonyl
  10       3.32 s                                                 35.1, CH         n\. o.            C-1, C-8, C-11, C-12, C-15, C-20
  11                                                              58.9, C                            
  12       3.49 br s                                              72.2, CH         H~2~-13           n\. o.
  13α/β    2.20 ddd (15.6, 3.2, 2.8); 1.98 ddd (15.6, 3.2, 3.2)   30.3, CH~2~      H-12, H-14        n\. o.
  14       5.01 dd (3.2, 3.2)                                     74.2, CH         H~2~-13           n\. o.
  15       1.24 s                                                 15.2, CH~3~                        C-1, C-2, C-10, C-14
  16a/b    5.36 d (1.6); 5.57 d (1.6)                             119.7, CH~2~                       C-4, C-6
  17       2.79 q (7.2)                                           49.6, CH         H~3~-18           C-18, C-19
  18       1.37 d (7.2)                                           7.4, CH~3~       H-17              C-8, C-17, C-19
  19                                                              174.2, C                           
  20a/b    2.76 d (3.2); 2.56 d (3.2)                             50.6, CH~2~                        n\. o.
  OAc-2                                                           170.2, C                           
           2.05 s                                                 20.5, CH~3~                        Acetate carbonyl
  OAc-3                                                           169.9, C                           
           2.08 s                                                 21.1, CH~3~                        Acetate carbonyl
  OAc-9                                                           169.5, C                           
           2.32 s                                                 21.1, CH~3~                        Acetate carbonyl
  OAc-14                                                          169.9, C                           
           2.00 s                                                 20.3, CH~3~                        Acetate carbonyl

^a^ n. o. = not observed.
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###### 

^1^H (400 MHz, CDCl~3~) and ^13^C (100 MHz, CDCl~3~) NMR data, ^1^H--^1^H COSY and HMBC correlations for briarane **2**

  C/H      δ~H~ (*J* in Hz)                           δ~C~, Multiple   ^1^H--^1^HCOSY   HMBC (H→C)
  -------- ------------------------------------------ ---------------- ---------------- ---------------------------------------------
  1                                                   47.0, C                           
  2        4.83 dd (6.0, 1.2)                         75.9, CH         H~2~-3           C-1, C-3, C-4, C-10, C-15, acetate carbonyl
  3α/β     1.72 m; 2.49 m                             31.8, CH~2~      H-2, H~2~-4      C-1, C-4
  4α/β     2.26 m; 2.59 m                             26.2, CH~2~      H~2~-3           C-3, C-5, C-6, C-16
  5                                                   146.7, C                          
  6        5.94 d (10.0)                              121.7, CH        H-7              C-4, C-16
  7        5.30 d (10.0)                              77.3, CH         H-6              C-5, C-6, C-8
  8                                                   83.2, C                           
  9        5.30 d (5.2)                               71.5, CH         H-10             C-1, C-7, C-8, C-10, C-11, acetate carbonyl
  10       3.31 d (5.2)                               42.2, CH         H-9              C-1, C-2, C-8, C-9, C-11, C-12, C-15, C-20
  11                                                  150.9, C                          
  12a/b    2.26 m; 2.18 m                             26.4, CH~2~      H~2~-13          C-11, C-13, C-14, C-20
  13a/b    2.01 m; 1.76 m                             27.4, CH~2~      H~2~-12, H-14    C-1, C-11, C-14
  14       4.72 dd (4.8, 1.6)                         73.8, CH         H~2~-13          C-1, C-2, C-10, C-12, C-13, C-15,
                                                                                        acetate carbonyl
  15       1.09 s                                     15.1, CH~3~                       C-1, C-2, C-10, C-14
  16a/b    4.28 dd (14.0, 5.2); 4.14 dd (14.0, 7.6)   68.9, CH~2~      OH-16            C-5, C-6
  17       2.47 q (7.2)                               42.6, CH         H~3~-18          C-8, C-18, C-19
  18       1.13 d (7.2)                               6.6, CH~3~       H-17             C-8, C-17, C-19
  19                                                  175.8, C                          
  20a/b    4.90 s; 5.06 s                             113.1, CH~2~                      C-10, C-11, C-12
  OAc-2                                               171.8, C                          
           2.01 s                                     21.1, CH~3~                       Acetate carbonyl
  OAc-9                                               169.4, C                          
           2.21 s                                     21.8, CH~3~                       Acetate carbonyl
  OAc-14                                              170.6, C                          
           1.91 s                                     21.2, CH~3~                       Acetate carbonyl
  OH-8     2.05 s                                                                       C-7, C-8, C-9, C-17
  OH-16    3.01 dd (7.6, 5.2)                                          H~2~-16          n\. o. ^a^

^a^ n. o. = not observed.
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###### 

Effects of **1**--**7** on iNOS and COX-2 protein expressions in LPS-stimulated macrophages.

  Compound   iNOS            COX-2           β-Actin
  ---------- --------------- --------------- ----------------
  Control    1.01 ± 0.15     7.07 ± 3.88     86.12 ± 8.75
  LPS        100 ± 11.26     100 ± 3.36      100 ± 0.07
  **1**      61.22 ± 3.82    88.09 ± 6.87    94.26 ± 2.3
  **2**      49.13 ± 4.15    80.08 ± 7.98    110.11 ± 3.16
  **3**      36.22 ± 13.28   43.64 ± 6.23    99.30 ± 16.53
  **4**      61.63 ± 21.36   81.55 ± 22.66   117.99 ± 6.04
  **5**      76.16 ± 21.90   58.94 ± 0.8     117.48 ± 13.63
  **6**      43.33 ± 10.82   68.87 ± 11.08   129.76 ± 25.75
  **7**      74.65 ± 18.02   47.49 ± 1.49    124.60 ± 18.10
  Dex. ^a^   30.83 ± 6.69    9.32 ± 3.47     100.88 ± 3.14

^a^ Dexamethasone (Dex., 10 μM) was used as a positive control.
